No statistical significances were found (P > 0.05) regarding the association between the studied CTLA-4 polymorphisms in PBMCs and patients' characteristics (age, gender, smoking history), NSCLC subtypes (SCC, AC, and LCC) and tumor staging (TNM and AJCC systems). The gene discussed is CTLA4; the disease is neoplasm.